These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 35876628)
1. Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study. Luo L; Shen R; Arora A; Orlow I; Busam KJ; Lezcano C; Lee TK; Hernando E; Gorlov I; Amos C; Ernstoff MS; Seshan VE; Cust AE; Wilmott J; Scolyer RA; Mann G; Nagore E; Funchain P; Ko J; Ngo P; Edmiston SN; Conway K; Googe PB; Ollila D; Lee JE; Fang S; Rees JR; Thompson CL; Gerstenblith M; Bosenberg M; Gould Rothberg B; Osman I; Saenger Y; Reynolds AZ; Schwartz M; Boyce T; Holmen S; Brunsgaard E; Bogner P; Kuan PF; Wiggins C; Thomas NE; Begg CB; Berwick M; Pigment Cell Melanoma Res; 2022 Nov; 35(6):605-612. PubMed ID: 35876628 [TBL] [Abstract][Full Text] [Related]
2. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma. Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K; JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664 [TBL] [Abstract][Full Text] [Related]
3. Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations. Williams EA; Montesion M; Shah N; Sharaf R; Pavlick DC; Sokol ES; Alexander B; Venstrom J; Elvin JA; Ross JS; Williams KJ; Tse JY; Mochel MC Mod Pathol; 2020 Dec; 33(12):2397-2406. PubMed ID: 32483240 [TBL] [Abstract][Full Text] [Related]
4. Spectrum and Frequency of BRAF Mutations in Skin Melanomas in the Dalmatian Region of Croatia. Bezić J; Tomić I; Pavić M Acta Dermatovenerol Croat; 2024 Mar; 32(1):75-76. PubMed ID: 38946192 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care. Heppt MV; Siepmann T; Engel J; Schubert-Fritschle G; Eckel R; Mirlach L; Kirchner T; Jung A; Gesierich A; Ruzicka T; Flaig MJ; Berking C BMC Cancer; 2017 Aug; 17(1):536. PubMed ID: 28797232 [TBL] [Abstract][Full Text] [Related]
9. BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage. Mar VJ; Wong SQ; Li J; Scolyer RA; McLean C; Papenfuss AT; Tothill RW; Kakavand H; Mann GJ; Thompson JF; Behren A; Cebon JS; Wolfe R; Kelly JW; Dobrovic A; McArthur GA Clin Cancer Res; 2013 Sep; 19(17):4589-98. PubMed ID: 23833303 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma. Yaman B; Akalin T; Kandiloğlu G Am J Dermatopathol; 2015 May; 37(5):389-97. PubMed ID: 25357015 [TBL] [Abstract][Full Text] [Related]
11. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile. Larsen AC Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168 [TBL] [Abstract][Full Text] [Related]
12. Spitz melanoma is a distinct subset of spitzoid melanoma. Raghavan SS; Peternel S; Mully TW; North JP; Pincus LB; LeBoit PE; McCalmont TH; Bastian BC; Yeh I Mod Pathol; 2020 Jun; 33(6):1122-1134. PubMed ID: 31900433 [TBL] [Abstract][Full Text] [Related]
14. Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients. Lally SE; Milman T; Orloff M; Dalvin LA; Eberhart CG; Heaphy CM; Rodriguez FJ; Lin CC; Dockery PW; Shields JA; Shields CL Ophthalmology; 2022 Jun; 129(6):679-693. PubMed ID: 35085662 [TBL] [Abstract][Full Text] [Related]
15. BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Bauer J; Büttner P; Murali R; Okamoto I; Kolaitis NA; Landi MT; Scolyer RA; Bastian BC Pigment Cell Melanoma Res; 2011 Apr; 24(2):345-51. PubMed ID: 21324100 [TBL] [Abstract][Full Text] [Related]
16. Clinical correlates of NRAS and BRAF mutations in primary human melanoma. Ellerhorst JA; Greene VR; Ekmekcioglu S; Warneke CL; Johnson MM; Cooke CP; Wang LE; Prieto VG; Gershenwald JE; Wei Q; Grimm EA Clin Cancer Res; 2011 Jan; 17(2):229-35. PubMed ID: 20975100 [TBL] [Abstract][Full Text] [Related]
17. Assessment of RAS-RAF-MAPK Pathway Mutation Status in Healthy Skin, Benign Nevi, and Cutaneous Melanomas: Pilot Study Using Droplet Digital PCR. Dobre EG; Nichita L; Popp C; Zurac S; Neagu M Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396984 [TBL] [Abstract][Full Text] [Related]